Loading…

Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan

Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinop...

Full description

Saved in:
Bibliographic Details
Published in:Acta myologica 2007-12, Vol.26 (3), p.159-164
Main Authors: Astejada, M N, Goto, K, Nagano, A, Ura, S, Noguchi, S, Nonaka, I, Nishino, I, Hayashi, Y K
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 164
container_issue 3
container_start_page 159
container_title Acta myologica
container_volume 26
creator Astejada, M N
Goto, K
Nagano, A
Ura, S
Noguchi, S
Nonaka, I
Nishino, I
Hayashi, Y K
description Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2949309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70133563</sourcerecordid><originalsourceid>FETCH-LOGICAL-p179t-58e4f40d7e896269cbff0359b2dc162b40fb7651e4b3b9b4b4af2ecb349db3a33</originalsourceid><addsrcrecordid>eNpVkM1OwzAQhHMA0ar0FZBPnIiU2I4TX5BQVf5UiQucI9tZt0aOHeykqFeenJSWCvaymtnVN9KcJdM8x1WKKcsmyTzG92wcShkv8EUyyStGWcGKafK1bCEY5zvRb3ZIuAZZ0Z60ssYZJewN2mtv_Xqvft5ab0ENVgSkQfRDgIi8Ru0QD2azi33w3cj4NP0GuUFZGG1wW7BHuHHoWXTCXSbnWtgI8-OeJW_3y9fFY7p6eXha3K3SLi95nxYVUE2zpoSKM8y4klpnpOASNypnWNJMy5IVOVBJJJdUUqExKEkobyQRhMyS2wO3G2QLjQLXB2HrLphWhF3than_X5zZ1Gu_rTGnnGR8BFwfAcF_DBD7ujVRgbXCgR9iXWY5IQXbJ139TTpF_NZOvgGY0YP5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70133563</pqid></control><display><type>article</type><title>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</title><source>PubMed Central</source><creator>Astejada, M N ; Goto, K ; Nagano, A ; Ura, S ; Noguchi, S ; Nonaka, I ; Nishino, I ; Hayashi, Y K</creator><creatorcontrib>Astejada, M N ; Goto, K ; Nagano, A ; Ura, S ; Noguchi, S ; Nonaka, I ; Nishino, I ; Hayashi, Y K</creatorcontrib><description>Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.</description><identifier>ISSN: 1128-2460</identifier><identifier>PMID: 18646565</identifier><language>eng</language><publisher>Italy: Pacini Editore SpA</publisher><subject>DNA - genetics ; Humans ; Japan - epidemiology ; Lamin Type A - genetics ; Lamin Type A - metabolism ; Lipodystrophy ; Membrane Proteins - genetics ; Membrane Proteins - metabolism ; Muscular Dystrophies - epidemiology ; Muscular Dystrophies - genetics ; Muscular Dystrophies - metabolism ; Mutation ; Nuclear Envelope - genetics ; Nuclear Envelope - metabolism ; Nuclear Proteins - genetics ; Nuclear Proteins - metabolism ; Polymerase Chain Reaction ; Prevalence ; The Japanese–French Workshop</subject><ispartof>Acta myologica, 2007-12, Vol.26 (3), p.159-164</ispartof><rights>Copyright 1981 by Gaetano Conte Academy, Napoli 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949309/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949309/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18646565$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Astejada, M N</creatorcontrib><creatorcontrib>Goto, K</creatorcontrib><creatorcontrib>Nagano, A</creatorcontrib><creatorcontrib>Ura, S</creatorcontrib><creatorcontrib>Noguchi, S</creatorcontrib><creatorcontrib>Nonaka, I</creatorcontrib><creatorcontrib>Nishino, I</creatorcontrib><creatorcontrib>Hayashi, Y K</creatorcontrib><title>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</title><title>Acta myologica</title><addtitle>Acta Myol</addtitle><description>Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.</description><subject>DNA - genetics</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Lamin Type A - genetics</subject><subject>Lamin Type A - metabolism</subject><subject>Lipodystrophy</subject><subject>Membrane Proteins - genetics</subject><subject>Membrane Proteins - metabolism</subject><subject>Muscular Dystrophies - epidemiology</subject><subject>Muscular Dystrophies - genetics</subject><subject>Muscular Dystrophies - metabolism</subject><subject>Mutation</subject><subject>Nuclear Envelope - genetics</subject><subject>Nuclear Envelope - metabolism</subject><subject>Nuclear Proteins - genetics</subject><subject>Nuclear Proteins - metabolism</subject><subject>Polymerase Chain Reaction</subject><subject>Prevalence</subject><subject>The Japanese–French Workshop</subject><issn>1128-2460</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpVkM1OwzAQhHMA0ar0FZBPnIiU2I4TX5BQVf5UiQucI9tZt0aOHeykqFeenJSWCvaymtnVN9KcJdM8x1WKKcsmyTzG92wcShkv8EUyyStGWcGKafK1bCEY5zvRb3ZIuAZZ0Z60ssYZJewN2mtv_Xqvft5ab0ENVgSkQfRDgIi8Ru0QD2azi33w3cj4NP0GuUFZGG1wW7BHuHHoWXTCXSbnWtgI8-OeJW_3y9fFY7p6eXha3K3SLi95nxYVUE2zpoSKM8y4klpnpOASNypnWNJMy5IVOVBJJJdUUqExKEkobyQRhMyS2wO3G2QLjQLXB2HrLphWhF3than_X5zZ1Gu_rTGnnGR8BFwfAcF_DBD7ujVRgbXCgR9iXWY5IQXbJ139TTpF_NZOvgGY0YP5</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Astejada, M N</creator><creator>Goto, K</creator><creator>Nagano, A</creator><creator>Ura, S</creator><creator>Noguchi, S</creator><creator>Nonaka, I</creator><creator>Nishino, I</creator><creator>Hayashi, Y K</creator><general>Pacini Editore SpA</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200712</creationdate><title>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</title><author>Astejada, M N ; Goto, K ; Nagano, A ; Ura, S ; Noguchi, S ; Nonaka, I ; Nishino, I ; Hayashi, Y K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p179t-58e4f40d7e896269cbff0359b2dc162b40fb7651e4b3b9b4b4af2ecb349db3a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>DNA - genetics</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Lamin Type A - genetics</topic><topic>Lamin Type A - metabolism</topic><topic>Lipodystrophy</topic><topic>Membrane Proteins - genetics</topic><topic>Membrane Proteins - metabolism</topic><topic>Muscular Dystrophies - epidemiology</topic><topic>Muscular Dystrophies - genetics</topic><topic>Muscular Dystrophies - metabolism</topic><topic>Mutation</topic><topic>Nuclear Envelope - genetics</topic><topic>Nuclear Envelope - metabolism</topic><topic>Nuclear Proteins - genetics</topic><topic>Nuclear Proteins - metabolism</topic><topic>Polymerase Chain Reaction</topic><topic>Prevalence</topic><topic>The Japanese–French Workshop</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Astejada, M N</creatorcontrib><creatorcontrib>Goto, K</creatorcontrib><creatorcontrib>Nagano, A</creatorcontrib><creatorcontrib>Ura, S</creatorcontrib><creatorcontrib>Noguchi, S</creatorcontrib><creatorcontrib>Nonaka, I</creatorcontrib><creatorcontrib>Nishino, I</creatorcontrib><creatorcontrib>Hayashi, Y K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta myologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Astejada, M N</au><au>Goto, K</au><au>Nagano, A</au><au>Ura, S</au><au>Noguchi, S</au><au>Nonaka, I</au><au>Nishino, I</au><au>Hayashi, Y K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan</atitle><jtitle>Acta myologica</jtitle><addtitle>Acta Myol</addtitle><date>2007-12</date><risdate>2007</risdate><volume>26</volume><issue>3</issue><spage>159</spage><epage>164</epage><pages>159-164</pages><issn>1128-2460</issn><abstract>Mutations in the genes for nuclear envelope proteins of emerin (EMD) and lamin A/C (LMNA) are known to cause Emery-Dreifuss muscular dystrophy (EDMD) and limb girdle muscular dystrophy (LGMD). We compared clinical features of the muscular dystrophy patients associated with mutations in EMD (emerinopathy) and LMNA (laminopathy) in our series. The incidence of laminopathy was slightly higher than that of emerinopathy. The age at onset of the disease in emerinopathy was variable and significantly older than in laminopathy. The initial symptom of emerinopathy was also variable, whereas nearly all laminopathy patients presented initially with muscle weakness. Calf hypertrophy was often seen in laminopathy, underscoring the importance of mutation screening for LMNA in childhood muscular dystrophy with calf hypertrophy. The clinical spectrum of emerinopathy is actually wider than previously known including EDMD, LGMD, conduction defects with minimal muscle/joint involvement, and their intermittent forms. Pathologically, no marked difference was observed between emerinopathy and laminopathy. Increased number and variation in size of myonuclei were detected. More precise observations using electron microscopy is warranted to characterize the detailed nuclear changes in nuclear envelopathy.</abstract><cop>Italy</cop><pub>Pacini Editore SpA</pub><pmid>18646565</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1128-2460
ispartof Acta myologica, 2007-12, Vol.26 (3), p.159-164
issn 1128-2460
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2949309
source PubMed Central
subjects DNA - genetics
Humans
Japan - epidemiology
Lamin Type A - genetics
Lamin Type A - metabolism
Lipodystrophy
Membrane Proteins - genetics
Membrane Proteins - metabolism
Muscular Dystrophies - epidemiology
Muscular Dystrophies - genetics
Muscular Dystrophies - metabolism
Mutation
Nuclear Envelope - genetics
Nuclear Envelope - metabolism
Nuclear Proteins - genetics
Nuclear Proteins - metabolism
Polymerase Chain Reaction
Prevalence
The Japanese–French Workshop
title Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emerinopathy%20and%20laminopathy%20clinical,%20pathological%20and%20molecular%20features%20of%20muscular%20dystrophy%20with%20nuclear%20envelopathy%20in%20Japan&rft.jtitle=Acta%20myologica&rft.au=Astejada,%20M%20N&rft.date=2007-12&rft.volume=26&rft.issue=3&rft.spage=159&rft.epage=164&rft.pages=159-164&rft.issn=1128-2460&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E70133563%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p179t-58e4f40d7e896269cbff0359b2dc162b40fb7651e4b3b9b4b4af2ecb349db3a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70133563&rft_id=info:pmid/18646565&rfr_iscdi=true